Hazardous Drugs: Addressing Occupational Health Risk in the Healthcare Industry
Advancements in pharmaceutical and biological technology have resulted in the introduction of more and more hazardous drugs each year. The rise in drug volume has also increased the potential for occupational exposure, which has triggered many healthcare organizations to re-evaluate current exposure control methods.
This article describes and discusses the healthcare organization’s internal risk assessment process as it relates to hazardous drug safety and systematically compares our identified best practices with those published in the guidelines.
Thank you for requesting this material from ASSE Body of Knowledge (BOK). However, since you are not a registered user of the BoK you cannot view this document. To become a registered user and see this document and important SH&E materials, please register
If you are already registered, please log in to view this resource.